Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy

Prostate

Volumn 72, Issue 1, 2012, Pages 108-115

  Wolters, Tineke ^a   Montironi, Rodolfo ^b   Mazzucchelli, Roberta ^b   Scarpelli, Marina ^b   Roobol, Monique J ^a   Van Den Bergh, Roderick C N ^a   Van Leeuwen, Pim J ^a   Hoedemaeker, Robert F ^c   Van Leenders, Geert J L H ^a   Schröder, Fritz H ^a   Van Der Kwast, Theodorus H ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c SINT FRANCISCUS GASTHUIS   (Netherlands)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

cystoprostatectomy; incidental prostate cancer; insignificant prostate cancer; radical prostatectomy; screening; T1c prostate cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CYSTECTOMY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 81855194437     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21415     Document Type: Article

References (22)

1. Sakr WA, Grignon JD, Heilbrun LK, Cassin BJ, Pontes JJ, Haas GP,. High grade prostatic intraepithelial neaoplasia (HG-PIN) and prostatic adenocarcinoma between the ages of 20-69: An autopsy study of 249 cases. In Vivo 1994; 8: 439-443.
2. Soos G, Tsakiris I, Szanto J, Turzo C, Haas PG, Dezso B,. The prevalence of prostate carcinoma and its precursor in Hungary: An autopsy study. Eur Urol 2005; 48: 739-744.
3. Sánchez-Chapado M, Olmedilla G, Cabeza M, Donat E, Ruiz A,. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study. Prostate 2003; 54: 238-247.
4. Haas GP, Delongchamps NB, Jones RF, Chandan V, Serio AM, Vickers AJ, Jumbelic M, Threatte G, Korets R, Lilja H, de la Roza G,. Needle biopsies on autopsy prostates: Sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst 2007; 99: 1484-1489.
5. Delongchamps NB, Mao K, Theng H, Zerbib M, Debré B, Peyromaure M,. Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer. Eur Urol 2005; 48: 946-950.
6. Rocco B, de Cobelli O, Leon ME, Ferruti M, Mastropasqua MG, Matei DV, Gazzano G, Verweij F, Scardino E, Musi G, Djavan B, Rocco F,. Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: Preliminary report. Eur Urol 2006; 49: 827-833.
7. Ruffion A, Manel A, Massoud W, Decaussin M, Berger N, Paparel P, Morel-Journel N, Lopez JG, Champetier D, Devonec M, Perrin P,. Preservation of prostate during radical cystectomy: Evaluation of prevalence of prostate cancer associated with bladder cancer. J Urol 2005; 65: 703-707.
8. Pettus JA, Al-Ahmadie H, Barocas DA, Koppie TM, Herr H, Donat SM, Dalbagni G, Reuter VE, Olgac S, Bochner B,. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 2008; 53: 370-375.
9. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA, Shappell SB,. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: Implications for possible apical sparing surgery. J Urol 2004; 171: 646-651.
10. Montironi R, Mazzucchelli R, Santinelli A, Scarpelli M, Lòpez-Beltran A, Bostwick DG,. Incidentally detected prostate cancer in cystoprostatectomies: Pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol 2005; 36 I (6): 646-654.
11. Epstein JI, Walsh PC, Carmicheal M, Brendler CB,. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368-1374.
12. Postma R, van Leenders GJHL, Roobol MJ, Schröder FH, van der Kwast ThH,. Tumour features in the control and screening arm of a randomized trial of prostate cancer. Eur Urol 2006; 50: 70-75.
13. Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berebnguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, Van der Kwast ThH, Blijenberg BG, Moss SM, De Koning HJ, Auvinen A,. Screening and prostate-cancer mortality in a randomized European Study. N Engl J Med 2009; 360: 1320-1328.
14. Mazzucchelli R, Barbisan F, Scarpelli M, Lopez-Beltran A, van der Kwast ThH, Cheng L, Montironi R,. Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant ? Am J Clin Pathol 2009; 131: 279-283.
15. Postma R, Schröder FH, van Leenders GJ, Hoedemaeker RF, Vis AN, Roobol MJ, van der Kwast TH,. Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)-Section Rotterdam. A comparison of two rounds of screening. Eur Urol 2007; 52: 89-97.
16. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A,. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-974.
17. Hoedemaeker RF, Ruijter ETG, Ruizeveld-de Winter JA, van der Kaa CA, van der Kwast ThH,. The BIOMED II MPC study group. Processing radical prostatectomy specimens. A comprehensive and standardized protocol. J Urol Pathol 1998; 9: 211-222.
18. Sobin LH, Wittekind C,. Urologic tumours: Prostate. In:, Sobin LH, Wittekind C, for the international union against cancer (UICC), editors. TNM classification of malignant tumours, 6th edition. New York, NY: Wiley-Liss; 2002. pp 184-187.
19. Hoedemaeker RF, Rietbergen JBW, Kranse R, van der Kwast ThH, Schröder FH,. Comparison of pathological characteristics of T1c and non-T1c cancers detected in a population-based screening study the European Randomized Study of Screening for Prostate Cancer. World J Urol 1997; 15 339-345
20. Scattoni V, Montironi R, Mazzucchelli R, Freschi M, Nava L, Losa A, Terrone C, Scarpa RM, Montorsi F, Pappagallo G, Rigatti P,. Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg. BJU Int 2006; 98: 54-58.
21. Wolters T, Roobol MJ, van Leeuwen PJ, van den Bergh RC, Hoedemaeker RF, van Leenders GJ, Schröder FH, van der Kwast TH,. Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer. Eur Urol 2010; 57: 821-829.
22. Konety BR, Bird VY, Deorah S, Dahmoush L,. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era. J Urol 2005; 174: 1785-1788.